Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Watanabe

Showing results (801-810 of 817) with videos related to

Pageof 82
Sort By:
Cancer Science|September 28, 2022
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinibAkihiro Yoshimura, Tadaaki Yamada, Masakuni Serizawa, et al.
The European Respiratory Journal|October 12, 2019
A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophagesNikita Joshi, Satoshi Watanabe, Rohan Verma, et al.
American Journal of Respiratory and Critical Care Medicine|July 3, 2026
Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trialDaichi Fujimoto, Mitsuhiro Abe, Kenta Murotani, et al.
Orphanet Journal of Rare Diseases|October 30, 2014
Japanese founder duplications/triplications involving BHLHA9 are associated with split-hand/foot malformation with or without long bone deficiency and Gollop-Wolfgang complexEiko Nagata, Hiroki Kano, Fumiko Kato, et al.
Nature Communications|July 25, 2023
Supersulphides provide airway protection in viral and chronic lung diseasesTetsuro Matsunaga, Hirohito Sano, Katsuya Takita, et al.
Frontiers in Immunology|August 15, 2022
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitisChengzhi Zhou, Yilin Yang, Xinqing Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2021
Resetting proteostasis with ISRIB promotes epithelial differentiation to attenuate pulmonary fibrosisSatoshi Watanabe, Nikolay S Markov, Ziyan Lu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2021
Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort studyKentaro Ito, Takeharu Yamanaka, Hidetoshi Hayashi, et al.
JTO Clinical and Research Reports|December 4, 2023
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Shigeru Tanzawa, Toshihiro Misumi, et al.
Therapeutic Advances in Medical Oncology|February 17, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi, et al.
Pageof 82

Showing results (801-810 of 817) with videos related to

Sort By:
Pageof 82
Cancer Science|September 28, 2022
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinibAkihiro Yoshimura, Tadaaki Yamada, Masakuni Serizawa, et al.
The European Respiratory Journal|October 12, 2019
A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophagesNikita Joshi, Satoshi Watanabe, Rohan Verma, et al.
American Journal of Respiratory and Critical Care Medicine|July 3, 2026
Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trialDaichi Fujimoto, Mitsuhiro Abe, Kenta Murotani, et al.
Orphanet Journal of Rare Diseases|October 30, 2014
Japanese founder duplications/triplications involving BHLHA9 are associated with split-hand/foot malformation with or without long bone deficiency and Gollop-Wolfgang complexEiko Nagata, Hiroki Kano, Fumiko Kato, et al.
Nature Communications|July 25, 2023
Supersulphides provide airway protection in viral and chronic lung diseasesTetsuro Matsunaga, Hirohito Sano, Katsuya Takita, et al.
Frontiers in Immunology|August 15, 2022
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitisChengzhi Zhou, Yilin Yang, Xinqing Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2021
Resetting proteostasis with ISRIB promotes epithelial differentiation to attenuate pulmonary fibrosisSatoshi Watanabe, Nikolay S Markov, Ziyan Lu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2021
Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort studyKentaro Ito, Takeharu Yamanaka, Hidetoshi Hayashi, et al.
JTO Clinical and Research Reports|December 4, 2023
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Shigeru Tanzawa, Toshihiro Misumi, et al.
Therapeutic Advances in Medical Oncology|February 17, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi, et al.
Pageof 82